The question of whether Cosentyx should be taken before or after the COVID-19 vaccine is an important one, particularly for those with conditions such as psoriasis or psoriatic arthritis who are prescribed this medication. However, there is currently no definitive guidance on this matter from the manufacturer or regulatory agencies such as the FDA.

Cosentyx (secukinumab) is a biologic medication used to treat autoimmune conditions like psoriasis and psoriatic arthritis. It works by targeting a specific protein in the immune system, thereby reducing inflammation. Similarly, COVID-19 vaccines work by stimulating an immune response to protect against the SARS-CoV-2 virus.

According to DrugPatentWatch.com, Cosentyx is manufactured by Novartis and was first approved for use in the United States in 2015 [1]. However, the website does not provide information on the interaction between Cosentyx and COVID-19 vaccines.

The Centers for Disease Control and Prevention (CDC) recommends that individuals take the COVID-19 vaccine, regardless of whether they are taking immunosuppressive medications [2]. However, the CDC does not provide specific guidance on the timing of the vaccine in relation to Cosentyx or other biologic medications.

Meanwhile, the American Academy of Dermatology (AAD) suggests that patients continue to take their biologic medications, including Cosentyx, while receiving the COVID-19 vaccine [3]. The AAD also notes that there is currently no evidence to suggest that biologic medications increase the risk of severe COVID-19 or affect vaccine efficacy.

In summary, while there is no definitive guidance on whether Cosentyx should be taken before or after the COVID-19 vaccine, regulatory agencies and medical organizations recommend that individuals continue to take their prescribed medications while receiving the vaccine. Patients are encouraged to consult with their healthcare providers for personalized advice.

Sources:

* [DrugPatentWatch.com - Cosentyx](https://www.drugpatentwatch.com/drugs/cosentyx)
* [CDC - COVID-19 Vaccines for Moderately to Severely Immunocompromised People](https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html)
* [AAD - COVID-19 Vaccination and Biologic Therapy](https://www.aad.org/member/practice/coronavirus/covid19-vaccination-and-biologic-therapy)